Joel Greenblatt's RGEN Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 50,531 shares of Repligen Corporation (RGEN) worth $8.28 M, representing 0.03% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in RGEN, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2016, adding 80,799 shares. Largest reduction occurred in Q4 2017, reducing 94,413 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Repligen Corporation (RGEN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Repligen Corporation (RGEN) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +7,318 | Add 16.93% | 50,531 | $163.86 |
| Q3 2025 | +19,647 | Add 83.37% | 43,213 | $133.67 |
| Q2 2025 | +618 | Add 2.69% | 23,566 | $124.38 |
| Q1 2025 | +16,246 | Add 242.41% | 22,948 | $127.24 |
| Q4 2024 | -24,539 | Reduce 78.55% | 6,702 | $143.94 |
| Q3 2024 | +13,501 | Add 76.10% | 31,241 | $148.82 |
| Q2 2024 | +12,955 | Add 270.74% | 17,740 | $126.06 |
| Q1 2024 | +33 | Add 0.69% | 4,785 | $183.92 |
| Q4 2023 | +174 | Add 3.80% | 4,752 | $179.80 |
| Q3 2023 | -11,976 | Reduce 72.35% | 4,578 | $159.01 |
| Q2 2023 | +11,463 | Add 225.16% | 16,554 | $141.46 |
| Q1 2023 | -2,101 | Reduce 29.21% | 5,091 | $168.36 |
| Q4 2022 | -687 | Reduce 8.72% | 7,192 | $169.31 |
| Q3 2022 | -3,056 | Reduce 27.95% | 7,879 | $187.08 |
| Q2 2022 | +3,049 | Add 38.66% | 10,935 | $162.41 |
| Q1 2022 | +1,598 | Add 25.41% | 7,886 | $188.05 |
| Q4 2021 | +327 | Add 5.49% | 6,288 | $264.79 |
| Q3 2021 | -769 | Reduce 11.43% | 5,961 | $289.05 |
| Q1 2021 | -458 | Reduce 6.37% | 6,730 | $194.35 |
| Q4 2020 | -1,718 | Reduce 19.29% | 7,188 | $191.57 |
| Q3 2020 | -913 | Reduce 9.30% | 8,906 | $147.54 |
| Q2 2020 | -895 | Reduce 8.35% | 9,819 | $123.64 |
| Q1 2020 | -1,281 | Reduce 10.68% | 10,714 | $96.51 |
| Q4 2019 | -27,703 | Reduce 69.78% | 11,995 | $92.54 |
| Q3 2019 | +23,682 | Add 147.86% | 39,698 | $76.68 |
| Q2 2019 | -6,526 | Reduce 28.95% | 16,016 | $85.98 |
| Q1 2019 | -9,852 | Reduce 30.41% | 22,542 | $59.09 |
| Q4 2018 | +15,587 | Add 92.74% | 32,394 | $52.73 |
| Q3 2018 | +3,696 | Add 28.19% | 16,807 | $55.45 |
| Q2 2018 | +1,553 | Add 13.44% | 13,111 | $47.06 |
| Q1 2018 | -12,917 | Reduce 52.78% | 11,558 | $36.17 |
| Q4 2017 | -94,413 | Reduce 79.41% | 24,475 | $36.28 |
| Q3 2017 | -2,737 | Reduce 2.25% | 118,888 | $38.32 |
| Q2 2017 | -5,439 | Reduce 4.28% | 121,625 | $41.44 |
| Q1 2017 | -2,495 | Reduce 1.93% | 127,064 | $35.20 |
| Q4 2016 | -10,957 | Reduce 7.80% | 129,559 | $30.82 |
| Q3 2016 | +80,799 | Add 135.30% | 140,516 | $30.19 |
| Q2 2016 | +22,522 | Add 60.55% | 59,717 | $27.36 |
| Q1 2016 | +13,243 | Add 55.29% | 37,195 | $26.83 |
| Q4 2015 | -1,436 | Reduce 5.66% | 23,952 | $28.31 |
| Q3 2015 | +25,388 | New Buy | 25,388 | $27.85 |
| Q1 2015 | -13,954 | Sold Out | 0 | $0.00 |
| Q4 2014 | +1,083 | Add 8.41% | 13,954 | $19.78 |
| Q3 2014 | -2,043 | Reduce 13.70% | 12,871 | $19.89 |
| Q2 2014 | -590 | Reduce 3.81% | 14,914 | $22.80 |
| Q1 2014 | -3,028 | Reduce 16.34% | 15,504 | $12.84 |
| Q4 2013 | +18,532 | New Buy | 18,532 | $13.65 |
Joel Greenblatt's Repligen Corporation Investment FAQs
Joel Greenblatt first purchased Repligen Corporation (RGEN) in Q4 2013, acquiring 18,532 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Repligen Corporation (RGEN) for 48 quarters since Q4 2013.
Joel Greenblatt's largest addition to Repligen Corporation (RGEN) was in Q3 2016, adding 140,516 shares worth $4.24 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 50,531 shares of Repligen Corporation (RGEN), valued at approximately $8.28 M.
As of the Q4 2025 filing, Repligen Corporation (RGEN) represents approximately 0.03% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Repligen Corporation (RGEN) was 140,516 shares, as reported at the end of Q3 2016.